Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Profit After Tax (2017 - 2025)

Historic Profit After Tax for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Profit After Tax rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 11361.79%. This contributed to the annual value of $861000.0 for FY2024, which is 8258.85% down from last year.
  • Organogenesis Holdings' Profit After Tax amounted to $21.6 million in Q3 2025, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Profit After Tax peaked at $51.0 million during Q4 2021, and registered a low of -$18.8 million during Q1 2025.
  • Its 5-year average for Profit After Tax is $5.7 million, with a median of $5.3 million in 2023.
  • In the last 5 years, Organogenesis Holdings' Profit After Tax surged by 145088.03% in 2024 and then tumbled by 79728.57% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Profit After Tax (Quarter) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then crashed by 107.59% to -$568000.0 in 2023, then soared by 1450.88% to $7.7 million in 2024, then skyrocketed by 181.08% to $21.6 million in 2025.
  • Its Profit After Tax was $21.6 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$18.8 million in Q1 2025.